We narrowed to 291 results for: Flp recombinase

1. CT336

   Plasmid

   #233662

   Purpose

   AND Gate Reporter to identify Cre and Flp recombination; FRT-STOP-FRT-loxP-STOP-loxP-GFP

   Depositor

   Wilson Wong

   Article

   Tous et al Sci Adv. 2025 May 9;11(19):eadt1971. doi

   Insert

   FRT-STOP-FRT-loxP-STOP-loxP-GFP
   

   Expression

   Mammalian

   Mutation

   None

   Available Since

   May 12, 2025

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pAAV-CAG-FlpO (AAV1)

   Viral Prep

   #183412-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-FlpO (#183412). In addition to the viral particles, you will also receive purified pAAV-CAG-FlpO plasmid DNA. CAG-driven expression of the recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Janelia Viral Tools

   Promoter

   CAG

   Available Since

   March 27, 2024

   Availability

   Academic Institutions and Nonprofits only

3. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV5)

   Viral Prep

   #87306-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Li Zhang

   Article

   Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

   Promoter

   EF1a

   Available Since

   July 22, 2020

   Availability

   Academic Institutions and Nonprofits only

4. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV9)

   Viral Prep

   #87306-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Li Zhang

   Article

   Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

   Promoter

   EF1a

   Available Since

   Jan. 26, 2021

   Availability

   Academic Institutions and Nonprofits only

5. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV1)

   Viral Prep

   #87306-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Li Zhang

   Article

   Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

   Promoter

   EF1a

   Available Since

   April 18, 2019

   Availability

   Academic Institutions and Nonprofits only

6. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV2)

   Viral Prep

   #87306-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Li Zhang

   Article

   Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

   Promoter

   EF1a

   Available Since

   Aug. 24, 2020

   Availability

   Academic Institutions and Nonprofits only

7. pAAV.TBG.PI.FLPo.rBG (AAV8)

   Viral Prep

   #236288-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.TBG.PI.FLPo.rBG (#236288). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.FLPo.rBG plasmid DNA. TBG-driven expression of the recombinase FLPo. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Melina Fan, Addgene Research Program

   Promoter

   TBG

   Available Since

   Oct. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

8. AAV pEF1a-DIO-FLPo-WPRE-hGHpA (AAV Retrograde)

   Viral Prep

   #87306-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from AAV pEF1a-DIO-FLPo-WPRE-hGHpA (#87306). In addition to the viral particles, you will also receive purified AAV pEF1a-DIO-FLPo-WPRE-hGHpA plasmid DNA. EF1a-driven, Cre dependent expression of the site-specific recombinase FlpO. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Li Zhang

   Article

   Zingg et al Neuron. 2017 Jan 4;93(1):33-47. doi: 10.

   Promoter

   EF1a

   Available Since

   July 22, 2020

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CAG-FlpO (AAV Retrograde)

   Viral Prep

   #183412-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-CAG-FlpO (#183412). In addition to the viral particles, you will also receive purified pAAV-CAG-FlpO plasmid DNA. CAG-driven expression of the recombinase FlpO. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Janelia Viral Tools

   Promoter

   CAG

   Available Since

   March 27, 2024

   Availability

   Academic Institutions and Nonprofits only

10. AAV phSyn1(S)-FlpO-bGHpA (AAV Retrograde)

    Viral Prep

    #51669-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from AAV phSyn1(S)-FlpO-bGHpA (#51669). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-FlpO-bGHpA plasmid DNA. hSyn-driven FlpO expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hongkui Zeng

    Article

    Madisen et al Neuron. 2015 Mar 4;85(5):942-58. doi: 10

    Promoter

    Syn

    Available Since

    Oct. 28, 2021

    Availability

    Academic Institutions and Nonprofits only

11. pAT03-Apr

    Plasmid

    #154756

    Purpose

    For curing of the resistance marker of RecET recombinase system in Acinetobacter baumannii, Aprar

    Depositor

    Sheng Yang

    Article

    Sun et al mSphere. 2020 Apr 1;5(2). pii: 5/2/e0089

    Insert

    FLP recombinase
    

    Expression

    Bacterial

    Available Since

    Aug. 24, 2020

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. LCMV:ECFP(loxP)(FRT)EYFP

    Plasmid

    #31304

    Depositor

    Gerhart Ryffel

    Article

    Ryffel et al Nucleic Acids Res. 2003 Apr 15. 31(8):e4

    Insert

    ECFP(loxP)(FRT)EYFP
    

    Use

    Cre/Lox; Flp/frt

    Expression

    Mammalian

    Available Since

    Oct. 14, 2011

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. LCMV:ECFP(FRT)EYFP

    Plasmid

    #31307

    Depositor

    Gerhart Ryffel

    Article

    Ryffel et al Nucleic Acids Res. 2003 Apr 15. 31(8):e4

    Insert

    ECFP(FRT)EYFP
    

    Use

    Flp/frt

    Expression

    Mammalian

    Available Since

    Oct. 14, 2011

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. pFUdioFRTeYFPW

    Plasmid

    #133998

    Purpose

    expresses eYFP upon coexpression with the recombinase flippase (Flp)

    Depositor

    Elly Nedivi

    Article

    Subramanian et al Cell Rep. 2019 Aug 6;28(6):1584-1595.e5.

    Insert

    eYFP
    

    Use

    Lentiviral; Flp/frt

    Expression

    Mammalian

    Mutation

    inverted and flanked by two incompatible FRT site…

    Promoter

    UbC

    Available Since

    May 11, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. TRE-FRT-MCS-WPRE-SV40 - GCH27

    Plasmid

    #230828

    Purpose

    AAV cloning vector for Flpo-dependent expression under the TRE promoter.

    Depositor

    Kimberly Ritola

    Type

    Empty backbone

    Use

    AAV; Cloning vector, flp/frt

    Available Since

    March 26, 2025

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. pAAV-CaMKIIa-Flpo (AAV8)

    Viral Prep

    #183535-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-Flpo (#183535). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-Flpo plasmid DNA. CamKIIa-driven expression of Flpo recombinase. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fan et al Cell. 2023 Feb 2;186(3):543-559.e19. doi

    Promoter

    CaMKII

    Available Since

    Oct. 8, 2025

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-EF1a-Flp-DOG-NW (AAV1)

    Viral Prep

    #75469-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-Flp-DOG-NW (#75469). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flp-DOG-NW plasmid DNA. EF1a-driven expression of Flp recombinase dependent on GFP (Flp-DOG); to be coinjected with GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Connie Cepko

    Article

    Tang et al Elife. 2016 May 20;5. pii: e15312. doi:

    Promoter

    EF-1a

    Available Since

    Feb. 19, 2020

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-EF1a-Flpo (AAV1)

    Viral Prep

    #55637-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    EF1a

    Available Since

    July 8, 2019

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-EF1a-Flpo (AAV2)

    Viral Prep

    #55637-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    EF1a

    Available Since

    March 18, 2024

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-EF1a-Flpo (AAV Retrograde)

    Viral Prep

    #55637-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Fenno et al Nat Methods. 2014 Jul;11(7):763-72. doi:

    Promoter

    EF1a

    Available Since

    April 2, 2019

    Availability

    Academic Institutions and Nonprofits only